HK1109858A1 - Pharmaceutical preparation for oral administration with controlled drug release in the small intestine colon and process of prepartion thereof - Google Patents

Pharmaceutical preparation for oral administration with controlled drug release in the small intestine colon and process of prepartion thereof

Info

Publication number
HK1109858A1
HK1109858A1 HK08103960.2A HK08103960A HK1109858A1 HK 1109858 A1 HK1109858 A1 HK 1109858A1 HK 08103960 A HK08103960 A HK 08103960A HK 1109858 A1 HK1109858 A1 HK 1109858A1
Authority
HK
Hong Kong
Prior art keywords
prepartion
oral administration
small intestine
pharmaceutical preparation
drug release
Prior art date
Application number
HK08103960.2A
Other languages
English (en)
Inventor
Gerd Jung
Albert Schaupp
Original Assignee
Pfleger R Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37496994&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1109858(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfleger R Chem Fab filed Critical Pfleger R Chem Fab
Publication of HK1109858A1 publication Critical patent/HK1109858A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK08103960.2A 2006-07-10 2008-04-09 Pharmaceutical preparation for oral administration with controlled drug release in the small intestine colon and process of prepartion thereof HK1109858A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06014244A EP1880718B1 (de) 2006-07-10 2006-07-10 Pharmazeutische Zubereitung für die orale Verabreichung mit gesteuerter Wirkstofffreisetzung im Dünndarm und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
HK1109858A1 true HK1109858A1 (en) 2008-06-27

Family

ID=37496994

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08103960.2A HK1109858A1 (en) 2006-07-10 2008-04-09 Pharmaceutical preparation for oral administration with controlled drug release in the small intestine colon and process of prepartion thereof

Country Status (22)

Country Link
US (2) US8221787B2 (xx)
EP (1) EP1880718B1 (xx)
JP (1) JP5424877B2 (xx)
KR (1) KR101451233B1 (xx)
CN (1) CN101495103B (xx)
AR (1) AR061860A1 (xx)
AT (1) ATE525065T1 (xx)
CA (1) CA2655838C (xx)
CL (1) CL2007002000A1 (xx)
DK (1) DK1880718T3 (xx)
EA (1) EA016683B1 (xx)
ES (1) ES2374158T3 (xx)
HK (1) HK1109858A1 (xx)
HR (1) HRP20110739T1 (xx)
IL (1) IL195931A (xx)
JO (1) JO2801B1 (xx)
MX (1) MX2009000379A (xx)
PL (1) PL1880718T3 (xx)
SI (1) SI1880718T1 (xx)
TW (1) TWI375573B (xx)
UA (1) UA95805C2 (xx)
WO (1) WO2008006506A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009130712A2 (en) * 2008-04-22 2009-10-29 Lupin Limited Controlled release pharmaceutical compositions of trospium
EP2133072A1 (en) 2008-06-13 2009-12-16 KRKA, D.D., Novo Mesto Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives
WO2010043408A2 (de) * 2008-10-17 2010-04-22 Ratiopharm Gmbh Mikroverkapseltes fesoterodin
DE102009001636A1 (de) * 2009-03-18 2010-09-23 Henkel Ag & Co. Kgaa Bleichmittel mit verzögertem Bleichbeginn
US20100303920A1 (en) * 2009-05-27 2010-12-02 Johan Hjartstam Aqueous Film Coating Composition / 841
RU2014109079A (ru) * 2011-08-12 2015-09-20 Бёрингер Ингельхайм Ветмедика Гмбх Фармацевтическая композиция с маскированным вкусом
WO2013090893A1 (en) * 2011-12-16 2013-06-20 Celanese Eva Performance Polymers, Inc. Gastroretentive controlled release vehicles that include ethylene copolymers, ethyl celluloses, and/or thermpoplastic polyurethanes
JP2013145174A (ja) * 2012-01-13 2013-07-25 Panasonic Corp 近接センサ
PL2958607T3 (pl) * 2013-05-02 2016-12-30 Powłoka cewnika balonowego
JP6168673B2 (ja) * 2015-10-07 2017-07-26 協和発酵キリン株式会社 アリールアルキルアミン化合物含有医薬組成物
ITUA20161799A1 (it) * 2016-03-18 2017-09-18 Recordati Ind Chimica E Farmaceutica S P A Composizione farmaceutica a rilascio prolungato comprendente cisteamina o un suo sale

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI101344B1 (fi) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta
US5840329A (en) * 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
JP3888064B2 (ja) * 2000-01-27 2007-02-28 田辺製薬株式会社 徐放性製剤およびその製法
US20030018061A1 (en) * 2000-01-28 2003-01-23 Kohei Ogawa Novel remedies with the use of beta 3 agonist
DE10013029A1 (de) * 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
IN192159B (xx) * 2000-05-15 2004-02-28 Ranbaxy Lab Ltd
US7229665B2 (en) * 2001-05-22 2007-06-12 Millipore Corporation Process of forming multilayered structures
TR200300510A2 (tr) * 2003-04-18 2004-11-22 Sanovel �La� Sanay� Ve T�Caret A.�. Dağılan alendronat mikropartikül formülasyonu
DK2210605T3 (en) * 2003-11-04 2017-05-22 Tcd Royalty Sub Llc Daily single dose doses of trospium.
JP4771956B2 (ja) * 2003-11-04 2011-09-14 スパーナス ファーマシューティカルズ インコーポレイテッド バイオアベイラビリティーエンハンサを含む第四級アンモニウム化合物の組成物

Also Published As

Publication number Publication date
AR061860A1 (es) 2008-09-24
CA2655838C (en) 2014-04-08
CN101495103A (zh) 2009-07-29
JO2801B1 (en) 2014-03-15
CN101495103B (zh) 2013-05-22
EA016683B1 (ru) 2012-06-29
IL195931A0 (en) 2009-09-01
JP2009542742A (ja) 2009-12-03
EP1880718B1 (de) 2011-09-21
IL195931A (en) 2014-02-27
JP5424877B2 (ja) 2014-02-26
ES2374158T3 (es) 2012-02-14
WO2008006506A1 (de) 2008-01-17
HRP20110739T1 (hr) 2011-11-30
US8221787B2 (en) 2012-07-17
DK1880718T3 (da) 2011-11-21
ATE525065T1 (de) 2011-10-15
CA2655838A1 (en) 2008-01-17
KR20090029830A (ko) 2009-03-23
SI1880718T1 (sl) 2011-11-30
MX2009000379A (es) 2009-04-14
KR101451233B1 (ko) 2014-10-15
PL1880718T3 (pl) 2012-02-29
US20120294938A1 (en) 2012-11-22
UA95805C2 (uk) 2011-09-12
TWI375573B (en) 2012-11-01
CL2007002000A1 (es) 2008-01-18
TW200808381A (en) 2008-02-16
EA200970100A1 (ru) 2009-06-30
EP1880718A1 (de) 2008-01-23
US20090285891A1 (en) 2009-11-19

Similar Documents

Publication Publication Date Title
HK1109858A1 (en) Pharmaceutical preparation for oral administration with controlled drug release in the small intestine colon and process of prepartion thereof
IL275854A (en) Pharmaceutical composition and its administration
HK1111902A1 (en) Controlled release complex formulation for oral administration of medicine for diabetes and method for the preparation thereof
ZA200900423B (en) Methods and medicaments for administration of ibuprofen
EP2007398A4 (en) HIGH ADMINISTRATION SPEEDS FOR LIPID DRUG PREPARATIONS AND METHODS OF TREATMENT THEREOF
HK1150390A1 (en) A pharmaceutical composition and the application thereof in the preparation of medicine for the treatment of cerebrovascular diseases
IL208832A (en) 3-Aminocarbazole Compound, Pharmaceutical Preparations Containing Them, Methods of Preparation and Use for Drug Preparation
EP2213318A4 (en) DRUG SOLUTION DELIVERY SYSTEM AND DRUG SOLUTION ADMINISTRATION CANNULA
IL199187A (en) Indole history, pharmaceuticals including them and their use in the manufacture of medicines
ZA200901110B (en) Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage from containing same
IL228017A0 (en) Quinazolinone derivatives donated at position 5 as anti-cancer agents
EP1986605A4 (en) APPARATUS AND FORMULAS FOR SUPRACHOROIDAL DELIVERY OF A MEDICINAL PRODUCT
IL193019A0 (en) Drug delivery systems containing weakly basic drugs and organic acids and methods for the preparation thereof
IL193727A0 (en) Dosage forms for administering combinations of drugs
IL196854A (en) Indole compounds and their appropriate pharmaceutical salts and their use in the preparation of @ drugs
GB0607105D0 (en) Enhancing solubility and dissolution rate of poorly soluble drugs
PL2308566T3 (pl) Zastosowanie doustnie podawanych probiotycznych bifidobakterii w celu uzyskania korzyści dla ludzkiego piękna
IL208355A (en) Annotations 7,3-Dihydroporin-6,2-Discussion, Processes for their Preparation, Pharmaceutical Preparations Containing them and their Use in Medication Preparation
IL200278A (en) Use of aclidinium for the manufacture of a drug for use in the treatment or prevention of respiratory illness and pharmacist's preparation for the treatment or prevention of respiratory illness
IL193094A (en) Appalidine and other drugs used in the manufacture of a cancer treatment drug when the combination of the two gives a synergistic result
IL204528A (en) Pharmaceutical dosage forms for immediate sustained release of metadoxin
HK1142823A1 (en) Formulations for the oral administration of therapeutic agents and related methods
IL203936A (en) HISTORY 4 - Pyrimidinsulfamide, Process for Preparation, Pharmaceutical Preparations Containing and Using it for Medication Preparation
HK1176548A1 (en) Pharmaceutical for oral delivery comprising mgbg and methods of treating disease mgbg
GB0403406D0 (en) Preparation of carriers for drug delivery and other therapeutic applications

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170710